We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
Analytical Cannabis Logo
×
Home > News
Cannabis & Psychedelics News

Washington Cannabis Stores Offer “Joints for Jabs” to Encourage Vaccine Uptake

The program permits participating retail stores to give away one pre-rolled cannabis joint to customers over the age of 21 who are receiving a vaccination.

Read More

Morocco Passes Medical Cannabis Legalization Bill

Morocco’s king will need to sign the legislation before it becomes law.

Read More

AOAC Approves Six Tests for Yeast and Mold Counts in Cannabis

A range of methods for quantifying yeast and mold in dried cannabis flower have been approved by AOAC International.

Read More

Medical Cannabis Significantly Improves Quality of Life, Finds Europe’s Largest Patient Study

Project Twenty21, Europe’s largest ever medical cannabis patient study, has released its first preliminary results – the first real-world data to be published on medical cannabis patients in the United Kingdom.

Read More

Harsh European Cannabis Laws Don’t Deter Frequent Consumers, Study Finds

The researchers found that while restrictive intervention does appear to decrease the share of adolescents initiating cannabis use, there was no evidence of policy changes impacting the share of frequent cannabis users.

Read More

THC and CBD Can Reduce Neural Activity in Juvenile Zebrafish, Study Finds

As zebrafish are accepted models for humans in scientific research (much like mice), the authors of the study say that these observed effects of prenatal cannabis exposure could be mirrored in humans.

Read More

MDMA-assisted Therapy Can Successfully Treat PTSD, Study Finds

The use of MDMA-assisted therapy for post-traumatic stress disorder (PTSD) has now proven itself in its first phase 3 clinical trial.

Read More

Synthetic Psychedelic Reduces Stress in Mice, Study Finds

Crucially, the scientists say, the benefits of the drug came without the cost of hallucinations, a side effect which may aggravate stress.

Read More

FDA Grants Authorization Allowing Research Institute to Study Psychedelic Use by Therapists

This comes after the FDA also recently allowed institutes to conduct clinical trials on MDMA and its therapeutic potential in treating PTSD.

Read More

 
Advertisement